Status:
ACTIVE_NOT_RECRUITING
The Role of Human Milk Oligosaccharides and Microbiomes on Infantile Colic and Atopic Dermatitis in Term Infants
Lead Sponsor:
National Cheng-Kung University Hospital
Conditions:
Infantile Colic
Breast Feeding
Eligibility:
All Genders
1+ years
Brief Summary
Background: Human milk oligosaccharides (HMO) and microbiota are both key factors for infants to shape the gut flora and develop the immune system. Breastfed infant is beneficial to prevent the occurr...
Detailed Description
Purpose: To investigate the preventive role of HMO-supplement formula on IC and AD in term infants in a clinical trial. Method: The investigators will enroll three cohorts (exclusive breastfeeding, f...
Eligibility Criteria
Inclusion
- New born
- Gestational age of \>= 37 weeks
- birth weight greater than 2500 gm
Exclusion
- Born with Perinatal insults
- Mother with antimicrobial agents 1 month before delivery
- Congenital abnormalities related to growth
- Major disease admitted to Level II or NICU
Key Trial Info
Start Date :
August 7 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05992493
Start Date
August 7 2023
End Date
August 30 2026
Last Update
November 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cheng Kung University & Hospital
Tainan, Taiwan, 704